Enhancing the QUAlity and Transparency Of health Research
Use your browser's Back button to return to your search results
|Reporting guideline provided for?
(i.e. exactly what the authors state in the paper)
|Reporting the chemical composition of medicinal plant extracts used in pharmacological, toxicological and clinical research studies.|
|Full bibliographic reference||Heinrich M, Jalil B, Abdel-Tawab M, Echeverria J, Kulić Ž, McGaw LJ, Pezzuto JM, Potterat O, Wang JB. Best Practice in the chemical characterisation of extracts used in pharmacological and toxicological research-The ConPhyMP-Guidelines. Front Pharmacol. 2022;13:953205.|
(full-text if available)
|Read the full-text of the ConPhyMP reporting guideline.|
|Reporting guideline acronym||ConPhyMP|
|Study design||Clinical trials, Experimental studies|
|Clinical area||Complementary and alternative medicine, Pharmaceutical medicine, Toxicology|
|Applies to the whole report or to individual sections of the report?||Harms/adverse effects/safety data, Intervention (exposure), Terminology/definitions|
|Additional information||An online fillable open-access ConPhyMP tool is also available via the GA (Society of Medicinal Plants and Natural Products Research) website at https://ga-online.org/best-practice/
|Record last updated on||August 16, 2023|
Some reporting guidelines are also available in languages other than English. Find out more in our Translations section.